Flutemazepam
From Wikipedia, the free encyclopedia
![]() |
|
Systematic (IUPAC) name | |
---|---|
7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one
|
|
Clinical data | |
Pregnancy category |
|
Routes of administration |
Oral |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | 52391-89-6 ![]() |
ATC code | none |
PubChem | CID 40344 |
ChemSpider | 36859 ![]() |
UNII | J8U5694BCW ![]() |
ChEMBL | CHEMBL291770 ![]() |
Chemical data | |
Formula | C16H12ClFN2O2 |
Molar mass | 318.730 |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Flutemazepam[1] was developed at a team at Stabilimenti Chimici Farmaceutici Riuniti SpA in the mid 1970s. Is a drug which is a 3-hydroxy benzodiazepine derivative and an analogue of temazepam that has hypnotic, sedative, amnesiac, anxiolytic, anticonvulsant and skeletal muscle relaxant properties. It is most closely related in structure to temazepam and is indicated for the treatment of severe insomnia.[2] Flutemazepam has properties similar to temazepam, and it has been found to be very effective for the treatment of severe states of anxiety, panic attacks, and severe insomnia.[3]
See also[edit]
References[edit]
- ^ GB Patent 1431282 - BENZODIAZEPINE COMPOUNDS FOR THEREPEUTICAL USE
- ^ "flutemazepam". psychotropics.dk. Retrieved 11 February 2009.
- ^ Ian K.M. Morton, Judith M. Hall. Concise Dictionary of Pharmacological agents. Springer, 1999. ISBN 0-7514-0499-3, ISBN 978-0-7514-0499-9